De meeste beleggers zullen hun wonden likken, maar dat betekent niet dat er geen kansen zijn. Analisten zien voldoende koopjes.
Fonds | Broker | Advies |
Royal Dutch Shell PLC -B- | Barclays | Overweight |
Royal Dutch Shell A | Barclays | Overweight |
Ten Cate NV (Kon.) | Royal Bank of Scotland | Buy |
DSM NV (Kon.) | Societe Generale | Buy |
DSM NV (Kon.) | Morgan Stanley | Underweight |
BAM Groep NV (Kon.) | Theodoor Gilissen | Buy |
CSM NV | Keijser Securities | Buy |
Imtech NV | KBC Securities | Buy |
Mediq NV | SNS | Buy |
ArcelorMittal | Bank of America-Merrill Lynch | Neutral |
Batenburg Beheer NV | SNS | Hold |
Hunter Douglas NV | Petercam | Buy |
Heijmans NV Cert. | Kepler Capital | Hold |
Van Lanschot NV | ING | Hold |